Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akshay Vaishnaw Insider Profile
4 Followers
Akshay Vaishnaw, President, R&D at Alnylam Pharma, holds 14.63K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Editas Medicine (Ticker: EDIT), holds ― shares in Scholar Rock Holding (Ticker: SRRK).
Akshay Vaishnaw has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Akshay Vaishnaw holds in companies
Most Profitable Insider Trade
The most profitable trade made by Akshay Vaishnaw
Akshay Vaishnaw's Trading History
Alnylam Pharma
Oct 01, 2020
President, R&D
Uninformative Sell
135.94K
$1.90M
Editas Medicine
―
Director
―
―
Scholar Rock Holding
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Akshay Vaishnaw's performance on stock
You May Also Like
Akshay Vaishnaw insider profile FAQ
What is the percentage of profitable transactions made by Akshay Vaishnaw?
The percentage of profitable transactions made by Akshay Vaishnaw is ―.
What is the average return per transaction made by Akshay Vaishnaw?
The average return per transaction made by Akshay Vaishnaw is ―.
What stocks does Akshay Vaishnaw hold?
Akshay Vaishnaw holds: ALNY, EDIT, SRRK stocks.
What was Akshay Vaishnaw’s latest transaction?
Akshay Vaishnaw latest transaction was an Uninformative Sell of $135.94K.
What was Akshay Vaishnaw's most profitable transaction?
Akshay Vaishnaw’s most profitable transaction was an Informative Buy of ALNY stock on November 30, 2015. The return on the trade was -57.80%.
What is Akshay Vaishnaw's role in Alnylam Pharma?
Akshay Vaishnaw's role in Alnylam Pharma is President, R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.